Skip to main content

Specialties
Resources for Physicians
Resources for Your Patients

Search Videos and More

search

Channel Categories

Cancer (103)
Cardiology, Heart & Vascular Surgery (3)
Diabetes & Endocrinology (1)
Gastroenterology (4)
Geriatric Medicine (1)
Neurology (1)
Neurosurgery (1)
Obstetrics & Gynecology (6)
Ophthalmology (2)
Orthopaedics (2)
Other Programs (1)
Otolaryngology (2)
Physical Medicine and Rehabilitation (1)
Psychiatry (1)
Pulmonology (2)
Rheumatology (1)
Urology (2)

Types

News (90)
CME Course (2)
Video Asset (11)

Conditions

[A06.4] Amebic liver abscess (1)
[C01] Tongue Cancer (1)
[C14] Throat Cancer (1)
[C18.9] Colorectal Cancer (1)
[C22.0] Liver cell carcinoma (1)
[C22.3] Angiosarcoma of liver (1)
[C22.8] Liver Cancer (3)
[C25.3] Pancreatic Cancer (6)
[C34.90] Lung Cancer (2)
[C43.0] Malignant melanoma of lip (1)
[C43.1] Malignant melanoma of eyelid, including canthus (1)
[C44.90] Skin Cancer (3)
[C50.1] Malignant neoplasm of central portion of breast (1)
[C50.919] Triple-negative Breast Cancer (5)
[C50.91] Malignant neoplasm of breast of unspecified site, female (1)
[C50.9] Malignant neoplasm of breast of unspecified site (1)
[C50] Breast Cancer (7)
[C53.0] Malignant neoplasm of endocervix (1)
[C53.1] Malignant neoplasm of exocervix (1)
[C53.8] Malignant neoplasm of overlapping sites of cervix uteri (1)
[C53.9] Malignant neoplasm of cervix uteri, unspecified (1)
[C53] Malignant neoplasm of cervix uteri (1)
[C61] Prostate Cancer (1)
[C64] Kidney Cancer (1)
[C71.9] Glioblastoma (2)
[C76.0] Head and Neck Cancer (2)
[C78.6] Secondary malignant neoplasm of retroperitoneum and peritoneum (1)
[C79.89] Secondary malignant neoplasm of other specified sites (1)
[C80.0] Disseminated malignant neoplasm, unspecified (1)
[C80.1] Malignant (primary) neoplasm, unspecified (2)
[C80] Malignant neoplasm without specification of site (1)
[D72.0] Genetic anomalies of leukocytes (1)
[G62.82] Radiation-induced polyneuropathy (1)
[H05.32] Deformity of orbit due to bone disease (1)
[I42.7] Cardiomyopathy due to drug and external agent (1)
[I42] Cardiomyopathy (1)
[K86.9] Disease of pancreas, unspecified (1)
[M89.9] Metabollic Bone Disease (1)
[N39.0] Urinary Tract Infection (1)
[Z15.01] BRCA1 and BRCA2 Mutations (1)
[Z68.5] Body mass index (BMI) pediatric (1)

Procedures

[0003U] Measurement of proteins associated with ovarian cancer in serum (3)
[0005U] Test for detecting genes associated with prostate cancer in urine (3)
[0014U] DNA test for detecting gene abnormality associated with blood and lymphatic system cancer in blood or bone marrow (1)
[0022U] DNA and RNA gene analysis for non-small cell lung cancer (1)
[0030U] Gene analysis of targeted sequences for warfarin drug response (1)
[0036U] Exome gene analysis for somatic mutation in tumor tissue (1)
[0067U] Protein expression profiling of 4 biomarkers of breast cancer in precancerous breast tissue (1)
[00702] Anesthesia for liver biopsy (accessed through the skin) (1)
[00732] Anesthesia for diagnostic examination of gallbladder and pancreatic, liver, and bile ducts using an endoscope (2)
[0102U] Gene sequence analysis panel of 17 genes associated with hereditary breast cancer and related disorders (1)
[0131U] Targeted mRNA sequence analysis of 13 genes associated with hereditary breast cancer and related disorders (1)
[0166U] Liver disease test panel in serum specimen (1)
[0172U] DNA gene analysis (BRCA1, DNA repair associated and BRCA2, DNA repair associated) for detection of mutations associated with breast cancer (1)
[01922] Anesthesia for X-ray or radiation therapy (1)
[19294] Preparation of tumor cavity and placement of radiation therapy applicator into breast for radiation therapy concurrent with partial breast removal (2)
[19303] Mastectomy (1)
[28540] Closed treatment of ankle joint bone dislocation (1)
[28545] Closed treatment of ankle joint bone dislocation under anesthesia (1)
[48150] Whipple Procedure (2)
[49327] Examination of abdomen with insertion of devices for radiation therapy using endoscope (1)
[58210] Abdominal removal of uterus, cervix, and lymph nodes on both sides of pelvis and aortic lymph node biopsy (1)
[77261] Management of radiation therapy, simple (12)
[77262] Management of radiation therapy, intermediate (2)
[77263] Management of radiation therapy, complex (1)
[77427] Radiation Therapy (1)
[77799] Administration of radiation therapy (10)
[78815] Nuclear medicine study with CT imaging skull base to mid-thigh (1)
[81479] Molecular pathology procedure (1)
[87086] Bacterial colony count, urine (1)
[87088] Bacterial urine culture (1)
[87184] Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral) (1)
[87186] Evaluation of antimicrobial drug (antibiotic, antifungal, antiviral), microdilution or agar dilution (1)
[96366] Infusion into a vein for therapy, prevention, or diagnosis (1)
[96377] Application of on-body injector for injection under skin (1)
[96401] Non-hormonal anti-neoplastic chemotherapy beneath the skin or into muscle (3)
[96402] Hormonal anti-neoplastic chemotherapy administration beneath the skin or into muscle (1)
[96405] Chemotherapy into a lesion, up to and including 7 lesions (2)
[96406] Chemotherapy into a lesion, more than 7 lesions (1)
[96409] Infusion of chemotherapy into a vein using push technique (2)
[99202] New patient outpatient visit, total time 15-29 minutes (1)
[99203] New patient outpatient visit, total time 30-44 minutes (1)
[99204] New patient outpatient visit, total time 45-59 minutes (1)
[99205] New patient outpatient visit, total time 60-74 minutes (1)
[99212] Established patient outpatient visit, total time 10-19 minutes (1)
[99213] Established patient outpatient visit, total time 20-29 minutes (1)
[99214] Established patient outpatient visit, total time 30-39 minutes (1)
[99215] Established patient outpatient visit, total time 40-54 minutes (1)

Showing 13 - 24 of 103 results

Previous| 1 | 2 | 3 ...9 |Next

UT Southwestern biochemist Zhijian ‘James’ Chen, Ph.D., earns prestigious Lasker Award

UT Southwestern biochemist Zhijian ‘James’ Chen, Ph.D., earns prestigious Lasker Award

Dr. Chen’s discovery of cGAS, which triggers innate immunity, also honored with Germany’s top scientific prize

Pathway tied to cancer-driving genome alterations identified

Pathway tied to cancer-driving genome alterations identified

Understanding how chromosome shattering occurs could lead to strategies to overcome therapy resistance, UTSW study shows

Widespread disparities exist in treating advanced cancers

Widespread disparities exist in treating advanced cancers

Likelihood of patients receiving FDA-approved immunotherapies for late-stage kidney and bladder cancers linked to race, socioeconomic factors, facility type

Basic Research: R01s – Drs. Todd Aguilera & You Zhang

Basic Research: R01s – Drs. Todd Aguilera & You Zhang

Doctor Spotlights

DARTBOARD Clinical Trial

DARTBOARD Clinical Trial

DARTBOARD (STU2021-0401: A Prospective Randomized Phase II Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer), an innovative, first-of-its-kind clinical trial, is now complete.

Markerless Radiation Erases a Reminder and Improves Breast Cancer Therapy

Markerless Radiation Erases a Reminder and Improves Breast Cancer Therapy

Breast cancer almost always leaves its mark on patients. Along with surgical scars and changes in breast size and shape, medical tattoos or semi-permanent marker dots and lines were drawn on the patient’s chest to align radiotherapy beams, like checkpoints on a map.

Upon Further RefleXion

Upon Further RefleXion

The RefleXion X1 radiation treatment platform is the first to integrate PET/CT imaging with a medical linear accelerator. Using a PET signal identifying the tumor while also depicting its biology, RefleXion treats patients with unique biology-guided radiotherapy (BgRT). The UT Southwestern Department of Radiation Oncology is one of a handful of centers worldwide with this treatment capability.

Upgrading HDR Brachytherapy

Upgrading HDR Brachytherapy

High-dose-rate (HDR) brachytherapy is a procedure where the patient receives a dose from a powerful radioactive source for a few minutes per treatment session, after which the source is removed. The radioactive source, stored in an afterloader unit, travels through special applicators that then deliver the dose to the site of the tumor.

A Beacon of Hope in the Fight Against Pancreatic Cancer

A Beacon of Hope in the Fight Against Pancreatic Cancer

Our Pancreatic Cancer Program’s vision is to build a future where all patients have improved survival, are empowered to overcome adversity, achieve the highest quality of life, and are fully supported to thrive alongside their providers.

The Future of Medicine Sparks Here

The Future of Medicine Sparks Here

This is UT Southwestern Medical Center, and this is where a spark happens. Join UT Southwestern Medical Center and find your spark.

New AI tool to detect possible metastatic breast cancer

New AI tool to detect possible metastatic breast cancer

By improving MRI sensitivity, a model developed by UT Southwestern could potentially eliminate unnecessary biopsies

Taking Robotic Surgery to the Next Level

Taking Robotic Surgery to the Next Level

From breast cancer to gastrointestinal tumors, UTSW faculty are shaping the future of robotic surgery.

Showing 13 - 24 of 103 results

Previous| 1 | 2 | 3 ...9 |Next

Powered by BROADCASTMED

About UT Southwestern Medical Center

UT Southwestern, one of the nation’s premier academic medical centers, integrates pioneering biomedical research with exceptional clinical care and education. The institution’s faculty members have received six Nobel Prizes and include 25 members of the National Academy of Sciences, 24 members of the National Academy of Medicine, and 14 Howard Hughes Medical Institute Investigators. The full-time faculty of more than 3,200 is responsible for groundbreaking medical advances and is committed to translating science-driven research quickly to new clinical treatments. UT Southwestern physicians provide care in more than 80 specialties to more than 120,000 hospitalized patients, more than 360,000 emergency room cases, and oversee nearly 5 million outpatient visits a year.